WALTHAM, Mass., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Repligen Corporation (RGEN), a life sciences company focused on bioprocessing technology leadership, today announced the commercial launch of TangenX® ...
For decades, therapeutic monoclonal antibody (mAb) production relied on traditional batch-based manufacturing using stainless steel systems. But as biopharmaceutical pipelines grow to meet rising ...
WALTHAM, Mass., July 31, 2025 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced Novasign and Repligen have ...
(MENAFN- EIN Presswire) EINPresswire/ -- The Tangential Flow Filtration market is dominated by a mix of global bioprocessing leaders and specialized filtration technology innovators. Companies are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback